Protagenic Therapeutics, Inc.\new Accounts Payable
Protagenic Therapeutics, Inc.\new (PTIX) had Accounts Payable of $999.69 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-19
- 2026-06-30: Accounts Payable, Current $999.69K.
- 2026-03-31: Accounts Payable, Current $949.52K.
- 2025-12-31: Accounts Payable, Current $2.03M.
- 2025-09-30: Accounts Payable, Current $1.64M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $999.69K 10-Q · filed 2026-08-19 |
| 2026-03-31 | $949.52K 10-Q · filed 2026-08-19 |
| 2025-12-31 | $2.03M 10-Q · filed 2026-03-09 |
| 2025-09-30 | $1.64M 10-Q · filed 2025-11-26 |
| 2025-06-30 | $2.08M 10-QT · filed 2025-09-10 |
| 2025-03-31 | $961.12K 10-K · filed 2026-08-14 |
| 2014-06-30 | $138.00K 10-K · filed 2014-10-14 |
| 2011-09-30 | $5.23M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $2.79M 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $4.47M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |